1. Home
  2. KNSA vs MIAX Comparison

KNSA vs MIAX Comparison

Compare KNSA & MIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$55.11

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

MIAX

Miami International Holdings Inc.

HOLD

Current Price

$37.65

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNSA
MIAX
Founded
2015
2007
Country
United Kingdom
United States
Employees
N/A
439
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.7B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
KNSA
MIAX
Price
$55.11
$37.65
Analyst Decision
Strong Buy
Buy
Analyst Count
7
7
Target Price
$60.86
$47.00
AVG Volume (30 Days)
492.0K
1.9M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
225.00
N/A
EPS
0.27
N/A
Revenue
$677,564,000.00
N/A
Revenue This Year
$37.48
N/A
Revenue Next Year
$17.87
$12.20
P/E Ratio
$204.43
N/A
Revenue Growth
60.09
N/A
52 Week Low
$26.27
$31.20
52 Week High
$59.87
$57.14

Technical Indicators

Market Signals
Indicator
KNSA
MIAX
Relative Strength Index (RSI) 63.62 32.41
Support Level $40.67 $34.02
Resistance Level $59.87 $44.46
Average True Range (ATR) 1.83 2.69
MACD 0.59 -0.47
Stochastic Oscillator 91.10 8.31

Price Performance

Historical Comparison
KNSA
MIAX

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

About MIAX Miami International Holdings Inc.

Miami International Holdings Inc is engaged in operating regulated financial marketplaces across multiple asset classes using proprietary technology platforms. The company operates exchange markets for options, equities, futures, and international listings through its MIAX Exchanges, MIAX Futures Exchange, and the Bermuda Stock Exchange. The company operates through four reportable segments: Options, which provides trading and market data services for listed equity and ETP options; Equities, which provides trading services for U.S. equities and ETPs; Futures, which provides futures trading and clearing services through MIAX Futures; and International, which provides listing services for capital market instruments through the Bermuda Stock Exchange and The International Stock Exchange.

Share on Social Networks: